NCT03947385 2026-01-27Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsIDEAYA BiosciencesPhase 1/2 Recruiting336 enrolled
NCT01927341 2021-02-18Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS TumorsPfizerPhase 1/2 Completed53 enrolled 17 charts